A pharma standardised continued process verification on BIOVIA Discoverant and halved FDA onsite audit time.
Inconsistent data standards across manufacturing analytics complicated CPV requirements. The firm implemented BIOVIA Discoverant to standardize and validate its procedures. The page states FDA onsite audit duration fell by 50% and analytics procedures were standardized.
Dassault Systèmes is a software group whose BIOVIA brand serves pharma with lab, data and manufacturing analytics tools such as Discoverant and Pipeline Pilot
This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.
Published by Dassault Systèmes on its own site — read the original case study on discover.3ds.com ↗
Related use cases
- 01A biopharma used BIOVIA Discoverant to cut non-value-added data work by 75%.
- 02A biopharma automated APQR creation and cut root cause investigation from a month to an hour.
- 03Transforming Content Operations for 2x Faster Time to Market
- 04Astellas: Breaking Access Barriers with Veeva Compliant Chat
- 05How Pacira Generated Deep Website Insights to Get Patients on Therapy Faster
- 06Reaching Underserved Communities with Smarter Targeting